Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03159208 · ClinicalTrials.gov registry record
Prediction of Functional Outcomes From Chronic Critical Illness
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 589
- Enrollment target
NCT03159208: Completed study, sponsored by University of North Carolina, Chapel Hill.
NCT03159208 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 589 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03159208 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 589 participants
- Enrollment target
Study Summary
The purpose of the study is to establish clinical determinants of poor cognitive and physical functional outcome of CCI patients so that the investigators may develop and validate a multi-dimensional clinical prediction model to more effectively inform decision making earlier in the course of the ICU care. The investigators hypothesize that multiple premorbid and acute factors measured early in the course of CCI will have strong independent associations with functional recovery. The investigators further hypothesize that social and economic factors are associated with long-term functional outcomes independent of the acute clinical problems.
Primary Outcome
Severe Physical Disability defined by requiring assistance with 4 of 6 or more Activities of Daily Living (ADLs).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 589 participants |
| Start Date | 2017-04-17 |
| Est. Completion | 2021-09-05 |
What the finished NCT03159208 record still lists
NCT03159208 is an observational study that tracks outcomes without assigning an intervention. The registered 589 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03159208 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03159208 about?
NCT03159208 is a clinical study titled "Prediction of Functional Outcomes From Chronic Critical Illness". The purpose of the study is to establish clinical determinants of poor cognitive and physical functional outcome of CCI patients so that the investigators may develop and validate a multi-dimensional clinical prediction model to more effectively inform decision making earlier in the course of the IC...
What is the current status of trial NCT03159208?
This trial is currently completed. The enrollment target is 589 participants. The study started on 2017-04-17. Estimated completion is 2021-09-05.
Who is sponsoring clinical trial NCT03159208?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01365169 · 590 participants · NA
Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"
- NCT03774758 · 590 participants
Biomarkers for Risk Stratification in Lung Cancer
- NCT04747626 · 590 participants · NA
B-SAFER: Branched Stented Anastomosis Frozen Elephant Trunk Repair
- NCT05722938 · 590 participants · Phase 3
Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI